'Real-world' Compensatory Behaviour with Low Nicotine Concentration E-liquid: Subjective Effects and Nicotine, Acrolein and Formaldehyde Exposure

Overview

Journal Addiction

Specialty Psychiatry

Date 2018 Jun 9

PMID 29882257

Citations 51

Authors

Lynne Dawkins

Sharon Cox

Maciej Goniewicz

Hayden McRobbie

Catherine Kimber

Mira Doig

Leon Kosmider

Affiliations

Soon will be listed here.

Abstract

Aims: To compare the effects of (i) high versus low nicotine concentration e-liquid, (ii) fixed versus adjustable power and (iii) the interaction between the two on: (a) vaping behaviour, (b) subjective effects, (c) nicotine intake and (d) exposure to acrolein and formaldehyde in e-cigarette users vaping in their everyday setting.

Design: Counterbalanced, repeated measures with four conditions: (i) low nicotine (6 mg/ml)/fixed power; (ii) low nicotine/adjustable power; (iii) high nicotine (18 mg/ml)/fixed power; and (iv) high nicotine/adjustable power.

Setting: London and the South East, England.

Participants: Twenty experienced e-cigarette users (recruited between September 2016 and February 2017) vaped ad libitum using an eVic Supreme™ with a 'Nautilus Aspire' tank over 4 weeks (1 week per condition).

Measurements: Puffing patterns [daily puff number (PN), puff duration (PD), interpuff interval (IPI)], ml of e-liquid consumed, changes to power (where permitted) and subjective effects (urge to vape, nicotine withdrawal symptoms) were measured in each condition. Nicotine intake was measured via salivary cotinine. 3-Hydroxypropylmercapturic acid (3-HPMA), a metabolite of the toxicant acrolein, and formate, a metabolite of the carcinogen formaldehyde, were measured in urine.

Findings: There was a significant nicotine concentration × power interaction for PD (P < 0.01). PD was longer with low nicotine/fixed power compared with (i) high nicotine/fixed power (P < 0.001) and (ii) low nicotine/adjustable power (P < 0.01). PN and liquid consumed were higher in the low versus high nicotine condition (main effect of nicotine, P < 0.05). Urge to vape and withdrawal symptoms were lower, and nicotine intake was higher, in the high nicotine condition (main effects of nicotine: P < 0.01). While acrolein levels did not differ, there was a significant nicotine × power interaction for formaldehyde (P < 0.05).

Conclusions: Use of a lower nicotine concentration e-liquid may be associated with compensatory behaviour (e.g. higher number and duration of puffs) and increases in negative affect, urge to vape and formaldehyde exposure.

Citing Articles

Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Wu A Cochrane Database Syst Rev. 2025; 1:CD010216.

PMID: 39878158 PMC: 11776059. DOI: 10.1002/14651858.CD010216.pub9.

Biomarkers of Nicotine and Toxicant Exposure by E-Liquid Nicotine Concentration Level among US Adult Exclusive E-Cigarette Users.

Dai H, Reyes S, Buckley J, Maloney P Cancer Epidemiol Biomarkers Prev. 2024; 34(1):42-50.

PMID: 39387549 PMC: 11717606. DOI: 10.1158/1055-9965.EPI-24-0955.

Understanding e-Cigarette Addictiveness: Triangulation of Focus Group and Netnographic Data.

Andreas M, Grundinger N, Wolber N, Szafran D, Gorig T, Mons U J Med Internet Res. 2024; 26:e57970.

PMID: 39353183 PMC: 11480685. DOI: 10.2196/57970.

Acute analgesic effect of nicotine vaping using three experimental pain induction tasks: a randomized, placebo-controlled laboratory study.

Bremmer M, Paladino M, Campbell A, Xia K, Tarran R, Hendershot C Psychopharmacology (Berl). 2024; 242(2):235-245.

PMID: 39120697 DOI: 10.1007/s00213-024-06669-8.

Partial Nicotine Reduction and E-Cigarette Users' Puffing Behaviors Among Adults Aged 21 to 35 Years: A Randomized Crossover Clinical Trial.

Ferdous T, Roy S, Chowdhury S, Jebai R, Maya L, DeCaprio A JAMA Netw Open. 2024; 7(7):e2422954.

PMID: 39058490 PMC: 11282440. DOI: 10.1001/jamanetworkopen.2024.22954.

References

Zhu S, Zhuang Y, Wong S, Cummins S, Tedeschi G . E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017; 358:j3262. PMC: 5526046. DOI: 10.1136/bmj.j3262. View

Etter J . A longitudinal study of cotinine in long-term daily users of e-cigarettes. Drug Alcohol Depend. 2016; 160:218-21. DOI: 10.1016/j.drugalcdep.2016.01.003. View

Hecht S, Carmella S, Kotandeniya D, Pillsbury M, Chen M, Ransom B . Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res. 2014; 17(6):704-9. PMC: 4481723. DOI: 10.1093/ntr/ntu218. View

Dawkins L, Kimber C, Doig M, Feyerabend C, Corcoran O . Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Psychopharmacology (Berl). 2016; 233(15-16):2933-41. DOI: 10.1007/s00213-016-4338-2. View

Vardavas C, Filippidis F, Agaku I . Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 Countries. Tob Control. 2014; 24(5):442-8. DOI: 10.1136/tobaccocontrol-2013-051394. View

Bernert J, Jacob 3rd P, Holiday D, Benowitz N, Sosnoff C, Doig M . Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: a round-robin study. Nicotine Tob Res. 2009; 11(12):1458-66. PMC: 3167685. DOI: 10.1093/ntr/ntp161. View

Hammond D, Fong G, Cummings K, Hyland A . Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev. 2005; 14(6):1370-5. DOI: 10.1158/1055-9965.EPI-04-0498. View

Russell M . Nicotine intake and its regulation. J Psychosom Res. 1980; 24(5):253-64. DOI: 10.1016/0022-3999(80)90015-x. View

Foulds J, Veldheer S, Yingst J, Hrabovsky S, Wilson S, Nichols T . Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res. 2014; 17(2):186-92. PMC: 4838001. DOI: 10.1093/ntr/ntu204. View

10.

Russell M, Wilson C, Patel U, Feyerabend C, COLE P . Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J. 1975; 2(5968):414-6. PMC: 1681802. DOI: 10.1136/bmj.2.5968.414. View

11.

Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H . Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology (Berl). 2017; 234(5):773-779. PMC: 5306435. DOI: 10.1007/s00213-016-4512-6. View

12.

Scherer G, Lee P . Smoking behaviour and compensation: a review of the literature with meta-analysis. Regul Toxicol Pharmacol. 2014; 70(3):615-28. DOI: 10.1016/j.yrtph.2014.09.008. View

13.

Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J . Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014; 16(10):1319-26. PMC: 4838028. DOI: 10.1093/ntr/ntu078. View

14.

Lopez A, Hiler M, Soule E, Ramoa C, Karaoghlanian N, Lipato T . Effects of Electronic Cigarette Liquid Nicotine Concentration on Plasma Nicotine and Puff Topography in Tobacco Cigarette Smokers: A Preliminary Report. Nicotine Tob Res. 2015; 18(5):720-3. PMC: 5896822. DOI: 10.1093/ntr/ntv182. View

15.

Dawkins L, Corcoran O . Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2013; 231(2):401-7. DOI: 10.1007/s00213-013-3249-8. View

16.

Ramoa C, Hiler M, Spindle T, Lopez A, Karaoghlanian N, Lipato T . Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob Control. 2015; 25(e1):e6-9. PMC: 4888876. DOI: 10.1136/tobaccocontrol-2015-052447. View

17.

Farsalinos K, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V . Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014; 4:4133. PMC: 3935206. DOI: 10.1038/srep04133. View

18.

Farsalinos K, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V . Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse. 2013; 7:139-46. PMC: 3772898. DOI: 10.4137/SART.S12756. View

19.

Shahab L, Goniewicz M, Blount B, Brown J, McNeill A, Alwis K . Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med. 2017; 166(6):390-400. PMC: 5362067. DOI: 10.7326/M16-1107. View

20.

Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead L, Hajek P . Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016; 9:CD010216. PMC: 6457845. DOI: 10.1002/14651858.CD010216.pub3. View